Discover a wealth of knowledge at Westonci.ca, where experts provide answers to your most pressing questions. Connect with a community of experts ready to help you find accurate solutions to your questions quickly and efficiently. Join our Q&A platform to connect with experts dedicated to providing accurate answers to your questions in various fields.
Sagot :
Clinical practitioners in the United States continue to underutilize inhaled corticosteroids in the management of mild-to-moderate adult asthma.
In a cohort of patients aged 18 and older with FEV(1) values between 60% and 100% of predicted normal, the aim of this experiment was to determine the clinical effects, health-related quality of life, cost, and cost-effectiveness of inhaled corticosteroid therapy.
We compared the use of inhaled corticosteroid therapy along with quick relievers (such as short-acting beta-agonists) on an as-needed basis to the use of quick relievers alone.
To predict symptoms, acute exacerbations, quality-adjusted life years (QALYs), health care expenses, and cost-effectiveness, evaluated in both dollars per QALY gained and dollars per symptom-free day gained, a mathematical simulation model was created.
Learn more about corticosteroids:
https://brainly.com/question/28255810
#SPJ4
The complete question is '' what is the cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model''.
We hope you found what you were looking for. Feel free to revisit us for more answers and updated information. We hope you found this helpful. Feel free to come back anytime for more accurate answers and updated information. Get the answers you need at Westonci.ca. Stay informed with our latest expert advice.